REQUEST A DEMO
Total
USD $0.00
Search more companies

Neurotrauma Center & Cuidamed S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neurotrauma Center & Cuidamed S.A.S Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Neurotrauma Center & Cuidamed S.A.S is an enterprise located in Colombia, with the main office in Bucaramanga. It operates in the Ambulatory Health Care Services industry. Neurotrauma Center & Cuidamed S.A.S was incorporated on February 25, 2013. Neurotrauma Center & Cuidamed S.A.S currently employs 35 (2026) people. The company’s latest financial report indicates a net sales revenue drop of 0.93% in 2025. There was a total growth of 56.84% in Neurotrauma Center & Cuidamed S.A.S’s total assets over the same period. In 2025, Neurotrauma Center & Cuidamed S.A.S’s net profit margin increased by 3.37%.

Headquarters
Avenida Gonzalez Valencia # 55 A - 28 Barrio Nuevo Sotomayor
Bucaramanga; Santander;

Contact Details: Purchase the Neurotrauma Center & Cuidamed S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Neurotrauma Center & Cuidamed S.A.S report to view the information.
Registered Capital:
Purchase the Neurotrauma Center & Cuidamed S.A.S report to view the information.
Financial Auditors:
Purchase the Neurotrauma Center & Cuidamed S.A.S report to view the information.
Incorporation Date:
February 25, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Neurotrauma Center & Cuidamed S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-0.93%
Total Operating Revenue
-0.93%
Net Profit/Loss for the Period
131.59%
Total Assets
56.84%
Total Equity
36.72%
Net Profit Margin
3.37%
Return on Equity (ROE)
3.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?